Morgan Stanley »

Nervgen Pharma Ord shares owned by Morgan Stanley

Quarter-by-quarter ownership of Nervgen Pharma Ord (NGENF) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Nervgen Pharma Ord

Tip: Access up to 7 years of quarterly data

All positions including Nervgen Pharma Ord held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nervgen Pharma Ord by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2026-03-31 $45k 12k 3.77

More positions owned by Morgan Stanley

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)

View all positions for Morgan Stanley

Top funds holding Nervgen Pharma Ord

PFG Investments
Bank of America Corporation
Royal Bank of Canada
Integrated Wealth Concepts
Valley Forge Investment Consultants Inc Adv
Bank Of Montreal
UBS Group
Patriot Financial Group Insurance Agency
Commonwealth Equity Services
Cetera Investment Advisers
McKinley Carter Wealth Services
Busey Trust Company
Sprott
TD Waterhouse Canada
Liberty Wealth Management

View all funds holding Nervgen Pharma Ord